Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,34 USD | -2,25% | -8,05% | +161,45% |
09/04 | Transcript : ADC Therapeutics SA - Special Call | |
04/04 | Sectorupdate: Gezondheidszorgaandelen dalen aan het eind van de middag | MT |
Omzet 2024 * | 80,92 mln. 75,69 mln. | Omzet 2025 * | 94,29 mln. 88,19 mln. | Marktkapitalisatie | 359 mln. 336 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -183 mln. -171 mln. | Nettowinst (verlies) 2025 * | -171 mln. -160 mln. | EV/omzet 2024 * | 5,16 x |
Nettoschuld 2024 * | 58,43 mln. 54,65 mln. | Nettoschuld 2025 * | 53,49 mln. 50,03 mln. | EV/omzet 2025 * | 4,38 x |
K/w-verhouding 2024 * |
-2,02
x | K/w-verhouding 2025 * |
-2,43
x | Werknemers | 274 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 65,63% |
Recentste transcriptie over ADC Therapeutics SA
1 dag | -2,25% | ||
1 week | -8,05% | ||
Lopende maand | -3,34% | ||
1 maand | +3,33% | ||
3 maanden | +62,55% | ||
6 maanden | +520,00% | ||
Lopend jaar | +161,45% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 09-05-22 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 19-12-22 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 03-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 01-06-19 |
Ron Squarer
CHM | Chairman | 57 | 01-04-20 |
Jean Bizzari
BRD | Director/Board Member | 69 | 01-07-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 0 M€ | 0,00% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.01% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 4,34 | -2,25% | 323 499 |
25-04-24 | 4,44 | -7,11% | 297 280 |
24-04-24 | 4,78 | -3,82% | 276 687 |
23-04-24 | 4,97 | +6,20% | 402 955 |
22-04-24 | 4,68 | -0,85% | 173 368 |
uitgestelde koers Nyse, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+161,45% | 359 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |